Vicenç Falcó

5.3k total citations
150 papers, 3.0k citations indexed

About

Vicenç Falcó is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Vicenç Falcó has authored 150 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Epidemiology, 54 papers in Infectious Diseases and 38 papers in Virology. Recurrent topics in Vicenç Falcó's work include Pneumocystis jirovecii pneumonia detection and treatment (39 papers), HIV Research and Treatment (37 papers) and HIV/AIDS drug development and treatment (36 papers). Vicenç Falcó is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (39 papers), HIV Research and Treatment (37 papers) and HIV/AIDS drug development and treatment (36 papers). Vicenç Falcó collaborates with scholars based in Spain, Palestinian Territory and United States. Vicenç Falcó's co-authors include Esteban Ribera, Albert Pahissa, Joaquín Burgos, Adrián Curran, I Ocaña, Benito Almirante, Manuel Crespo, Jordi Navarro, T. Fernández de Sevilla and José Alegre and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Vicenç Falcó

140 papers receiving 2.9k citations

Peers

Countries citing papers authored by Vicenç Falcó

Since Specialization

Citations

This map shows the geographic impact of Vicenç Falcó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicenç Falcó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicenç Falcó more than expected).

Fields of papers citing papers by Vicenç Falcó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicenç Falcó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicenç Falcó. The network helps show where Vicenç Falcó may publish in the future.

Co-authorship network of co-authors of Vicenç Falcó

This figure shows the co-authorship network connecting the top 25 collaborators of Vicenç Falcó. A scholar is included among the top collaborators of Vicenç Falcó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicenç Falcó. Vicenç Falcó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Stefania Landolfi, Josep Castellví, Félix Pumarola, (unknown), (unknown), Juan Lorente, (unknown), Júlia G. Prado, Enrique Martín‐Gayo, Vicenç Falcó, Meritxell Genescà, María J. Buzón	0
2	Trichophyton mentagrophytes Genotype VII and Sexually Transmitted Tinea: An Observational Study in Spain 2025 ·Mycoses ·(unknown), Marı́a Gómez, (unknown), Jorge García, Laura Alcázar‐Fuoli, Luis López‐Pérez, David Téllez, (unknown), Elena Sulleiro, Vicenç Falcó, Maider Arando	5
3	Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol 2025 ·BMJ Open ·Eugènia Negredo, (unknown), (unknown), Vicenç Falcó, Àngel Rivero, (unknown), (unknown), (unknown), Juliessa M. Pavon, (unknown), (unknown), (unknown), (unknown), Lucía Bailón, Daniel Aguilar, Francis Ruiz, Cristina Miranda, Jordi Puig, (unknown), Julián Olalla	0
4	NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control 2024 ·JCI Insight ·(unknown), (unknown), Antonio Astorga-Gamaza, Norma Rallón, José M. Benito, Ezequiel Ruíz-Mateos, Adrián Curran, Joaquín Burgos, Jordi Navarro, Paula Suanzes, Vicenç Falcó, Meritxell Genescà, María J. Buzón	4
5	Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis 2024 ·Open Forum Infectious Diseases ·Daniel K. Nomah, Yesika Díaz, Andreu Bruguera, (unknown), Jordi Aceitón, Juliana Reyes‐Urueña, Josep M. Llibre, Vicenç Falcó, Arkaitz Imaz, Francisco Fanjul, Joaquim Peraire, Elisabet Deig, Peré Domingo, Alexy Inciarte, Jordi Casabona, José M Miró	2
6	Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain. 2023 ·European Journal of Internal Medicine ·Jordi Navarro, Adrián Curran, Berta Raventós, Jorge García, Paula Suanzes, Vicente Descalzo, (unknown), Núria Espinosa, Marisa Montes, Inés Suárez‐García, Concha Amador, Roberto Muga, Vicenç Falcó, Joaquín Burgos	6
7	Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022 2023 ·International Journal of STD & AIDS ·(unknown), Blanca Borràs-Bermejo, (unknown), Andrés Antón, María Piñana, Jorge García, Vicente Descalzo, (unknown), Xavier Martínez‐Gómez, Vicenç Falcó, Maider Arando	9
8	Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab 2019 ·Nature Communications ·Carla Serra‐Peinado, Judith Grau-Expósito, (unknown), Antonio Astorga-Gamaza, Jordi Navarro, (unknown), (unknown), Adrián Curran, Joaquín Burgos, Esteban Ribera, Berta Raventós, (unknown), Ariadna Torrella, Bibiana Planas, (unknown), Felipe García, Josep Castellví, Meritxell Genescà, Vicenç Falcó, María J. Buzón	34
9	Ceftobiprole medocaril for the treatment of community-acquired pneumonia 2018 ·Expert Opinion on Pharmacotherapy ·Vicenç Falcó, Joaquín Burgos, Benito Almirante	20
10	Native vertebral osteomyelitis in aged patients: distinctive features. An observational cohort study 2018 ·Infection ·Carles Pigrau, Núria Fernández-Hidalgo, Dolors Rodríguez-Pardo, Vicenç Falcó, Mayli Lung, Ferrán Pellisé, Benito Almirante	13
11	Impact of an Adherence Program to Antiretroviral Treatment on Virologic Response in a Cohort of Multitreated and Poorly Adherent HIV-Infected Patients in Spain 2014 ·AIDS Patient Care and STDs ·Jordi Navarro, Mercè Pérez‐Riba, Adrián Curran, Joaquín Burgos, María Feijoo-Cid, Ariadna Torrella, Estrella Caballero, I Ocaña, Esteban Ribera, Manel Crespo, Vicenç Falcó	6
12	Impact of influenza season and environmental factors on the clinical presentation and outcome of invasive pneumococcal disease 2014 ·European Journal of Clinical Microbiology & Infectious Diseases ·Joaquín Burgos, Nieves Larrosa, A. Martinez, Jordina Belmonte, Juan José González‐López, Jordi Rello, Tomàs Pumarola, Albert Pahissa, Vicenç Falcó	7
13	Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Arkaitz Imaz, S Villar del Saz, (unknown), Adrián Curran, Estrella Caballero, Vicenç Falcó, Manel Crespo, I Ocaña, (unknown), Enrique Ruíz de Gopegui, Melcior Riera, Esteban Ribera	41
14	Response‐Guided Therapy for Chronic Hepatitis C Virus Infection in Patients Coinfected with HIV: A Pilot Trial 2009 ·Clinical Infectious Diseases ·Eva Van den Eynde, Manuel Crespo, Juan Ignacio Esteban, R Jardí, Esteban Ribera, (unknown), Francisco Rodríguez‐Frias, Vicenç Falcó, Adrián Curran, Arkaitz Imaz, S Villar del Saz, I Ocaña, Rafael Esteban, Albert Pahissa	15
15	Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study) 2008 ·HIV Clinical Trials ·Esteban Ribera, (unknown), Adrián Curran, Sílvia Sauleda, Elena García‐Arumí, Eva Castellà, C. Puiggròs, Manuel Crespo, María Feijoo-Cid, (unknown), S Villar del Saz, M. Planas, D. Sureda, Vicenç Falcó, I Ocaña, Albert Pahissa	44
16	Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis 2007 ·Journal of Antimicrobial Chemotherapy ·Esteban Ribera, Carlos Azuaje, Rosa María López, Peré Domingo, Adrián Curran, María Feijoo-Cid, Leonor Pou, (unknown), M. A. Sambeat, (unknown), (unknown), Manuel Crespo, Vicenç Falcó, I Ocaña, Albert Pahissa	36
17	Peginterferon alpha‐2b plus ribavirin vs interferon alpha‐2b plus ribavirin for chronic hepatitis C in HIV‐coinfected patients 2006 ·Journal of Viral Hepatitis ·Manuel Crespo, Sílvia Sauleda, Juan Ignacio Esteban, (unknown), Esteban Ribera, Antoni L. Andreu, Vicenç Falcó, Josep Quer, I Ocaña, Isabel Ruíz-Camps, Marı́a Buti, Albert Pahissa, Rafael Esteban, J Guàrdia	47
18	Lactic acidosis related to nucleoside therapy in HIV-infected patients 2003 ·Expert Opinion on Pharmacotherapy ·Vicenç Falcó, Manuel Crespo, Esteban Ribera	19
19	Meningitis estreptocócicas no neumocócicas: características clínicas y microbiológicas de 13 casos 2003 ·Medicina Clínica ·(unknown), Vicenç Falcó, Benito Almirante, I Gasser, Carlos Pigrau, Albert Pahissa	4
20	[34-year-old male with HIV infection hospitalized for fever and respiratory failure]. 1995 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Vicenç Falcó	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact